Literature DB >> 2516622

Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens.

B A Claesson1, B Trollfors, I Brolin, M Granström, J Henrichsen, U Jodal, P Juto, I Kallings, K Kanclerski, T Lagergård.   

Abstract

The serologic responses to bacterial and viral antigens were determined in paired serum samples from 336 children, ages 1 month to 15 years, with roentgenographically verified community-acquired pneumonia. Significant increases in antibodies against one agent were found in 40% and against two or more agents in 8% of the children. There were significant increases in antibodies against respiratory syncytial virus in 20%, viruses of the influenza-parainfluenza group in 6% and adenovirus in 3%. A serologic response to one or more of the pneumococcal antigens used (type-specific capsular polysaccharide, C-polysaccharide and pneumolysin) was demonstrated in 13% of the patients. Ten percent of the children had significant increases in antibodies against Mycoplasma pneumoniae. Only three patients had increases against Haemophilus influenzae type b and one each against Legionella pneumophila and Chlamydia. Respiratory syncytial virus was the predominant etiologic agent in young children whereas M. pneumoniae was more frequent in the older age group.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2516622     DOI: 10.1097/00006454-198912000-00006

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  34 in total

1.  Streptococcus pneumoniae and Mycoplasma pneumoniae coinfection in community acquired pneumonia.

Authors:  P Toikka; T Juvén; R Virkki; M Leinonen; J Mertsola; O Ruuskanen
Journal:  Arch Dis Child       Date:  2000-11       Impact factor: 3.791

2.  Errors in registered birth weight and its implications for mortality statistics.

Authors:  D Anand; P O Pharoah
Journal:  Arch Dis Child       Date:  2000-11       Impact factor: 3.791

3.  British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood.

Authors: 
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

4.  Rationalised prescribing for community acquired pneumonia: a closed loop audit.

Authors:  H Clements; T Stephenson; V Gabriel; T Harrison; M Millar; A Smyth; W Tong; C J Linton
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

5.  Etiology and response to antibiotic therapy of community-acquired pneumonia in French children.

Authors:  D Gendrel; J Raymond; F Moulin; J L Iniguez; S Ravilly; F Habib; P Lebon; G Kalifa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

Review 6.  Clinical use of cefuroxime in paediatric community-acquired pneumonia.

Authors:  C Olivier
Journal:  Paediatr Drugs       Date:  2000 Sep-Oct       Impact factor: 3.022

7.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

8.  Pneumolysin PCR-based diagnosis of invasive pneumococcal infection in children.

Authors:  P Toikka; S Nikkari; O Ruuskanen; M Leinonen; J Mertsola
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 9.  Community-acquired pneumonia in children: issues in optimizing antibacterial treatment.

Authors:  Matti Korppi
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

10.  Epidemiological and economic burden of pneumococcal diseases in Canadian children.

Authors:  Geneviève Petit; Philippe De Wals; Barbara Law; Theresa Tam; Lonny James Erickson; Maryse Guay; Alicia Framarin
Journal:  Can J Infect Dis       Date:  2003-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.